Empowering dialysis users and caregivers
Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Professional dialysis recruitment| Affymax, Takeda announce US FDA acceptance of NDA for peginesatide - pharmabiz.com |
 |
 |
|
pharmabiz.com If approved, peginesatide will be the first once-monthly Erythropoiesis Stimulating Agent (ESA) available for the treatment of anaemia associated with CKD patients on dialysis in the United States. Peginesatide is a synthetic, PEGylated peptidic |
